TY - JOUR
T1 - Dopaminergic Modulation of Effort-Related Choice Behavior as Assessed by a Progressive Ratio Chow Feeding Choice Task
T2 - Pharmacological Studies and the Role of Individual Differences
AU - Randall, Patrick A.
AU - Pardo, Marta
AU - Nunes, Eric J.
AU - López Cruz, Laura
AU - Vemuri, V. Kiran
AU - Makriyannis, Alex
AU - Baqi, Younis
AU - Müller, Christa E.
AU - Correa, Mercè
AU - Salamone, John D.
N1 - Funding Information:
J. Salamone's work was funded by the NIH(NIMH) and NIH(NIDA), and he has received compensation from Merck- Seronno, Pfizer and Roche. A. Makriyannis was supported by NIH(NIDA). C. Müller received funding by UCB Pharma within the Biopharma collaborative project Neuroallianz funded by the German Federal Ministry of Education and Research (BMBF). M. Correa received funding by Fundació Bancaixa-UJI (P1.1B2010-43). M. Pardo was supported by Fundació Bancaixa-UJI (PREDOC-2007-43), and L. López-Cruz was supported by Ministerio Educación, FPU (AP2010-3793). None of the other authors had financial interests to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
PY - 2012/10/22
Y1 - 2012/10/22
N2 - Mesolimbic dopamine (DA) is involved in behavioral activation and effort-related processes. Rats with impaired DA transmission reallocate their instrumental behavior away from food-reinforced tasks with high response requirements, and instead select less effortful food-seeking behaviors. In the present study, the effects of several drug treatments were assessed using a progressive ratio (PROG)/chow feeding concurrent choice task. With this task, rats can lever press on a PROG schedule reinforced by a preferred high-carbohydrate food pellet, or alternatively approach and consume the less-preferred but concurrently available laboratory chow. Rats pass through each ratio level 15 times, after which the ratio requirement is incremented by one additional response. The DA D2 antagonist haloperidol (0.025-0.1 mg/kg) reduced number of lever presses and highest ratio achieved but did not reduce chow intake. In contrast, the adenosine A2A antagonist MSX-3 increased lever presses and highest ratio achieved, but decreased chow consumption. The cannabinoid CB1 inverse agonist and putative appetite suppressant AM251 decreased lever presses, highest ratio achieved, and chow intake; this effect was similar to that produced by pre-feeding. Furthermore, DA-related signal transduction activity (pDARPP-32(Thr34) expression) was greater in nucleus accumbens core of high responders (rats with high lever pressing output) compared to low responders. Thus, the effects of DA antagonism differed greatly from those produced by pre-feeding or reduced CB1 transmission, and it appears unlikely that haloperidol reduces PROG responding because of a general reduction in primary food motivation or the unconditioned reinforcing properties of food. Furthermore, accumbens core signal transduction activity is related to individual differences in work output.
AB - Mesolimbic dopamine (DA) is involved in behavioral activation and effort-related processes. Rats with impaired DA transmission reallocate their instrumental behavior away from food-reinforced tasks with high response requirements, and instead select less effortful food-seeking behaviors. In the present study, the effects of several drug treatments were assessed using a progressive ratio (PROG)/chow feeding concurrent choice task. With this task, rats can lever press on a PROG schedule reinforced by a preferred high-carbohydrate food pellet, or alternatively approach and consume the less-preferred but concurrently available laboratory chow. Rats pass through each ratio level 15 times, after which the ratio requirement is incremented by one additional response. The DA D2 antagonist haloperidol (0.025-0.1 mg/kg) reduced number of lever presses and highest ratio achieved but did not reduce chow intake. In contrast, the adenosine A2A antagonist MSX-3 increased lever presses and highest ratio achieved, but decreased chow consumption. The cannabinoid CB1 inverse agonist and putative appetite suppressant AM251 decreased lever presses, highest ratio achieved, and chow intake; this effect was similar to that produced by pre-feeding. Furthermore, DA-related signal transduction activity (pDARPP-32(Thr34) expression) was greater in nucleus accumbens core of high responders (rats with high lever pressing output) compared to low responders. Thus, the effects of DA antagonism differed greatly from those produced by pre-feeding or reduced CB1 transmission, and it appears unlikely that haloperidol reduces PROG responding because of a general reduction in primary food motivation or the unconditioned reinforcing properties of food. Furthermore, accumbens core signal transduction activity is related to individual differences in work output.
UR - http://www.scopus.com/inward/record.url?scp=84867708978&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867708978&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0047934
DO - 10.1371/journal.pone.0047934
M3 - Article
C2 - 23110135
AN - SCOPUS:84867708978
SN - 1932-6203
VL - 7
JO - PloS one
JF - PloS one
IS - 10
M1 - e47934
ER -